# FDA Inspection 1223147 - ReproTech LLC - November 16, 2023

Source: https://www.keypedia.com/records/fda_inspections/reprotech-llc/609761b5-2b6a-4466-a178-6a79ee2fd7bb
Source feed: FDA_Inspections

> FDA Inspection 1223147 for ReproTech LLC on November 16, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1223147
- Company Name: ReproTech LLC
- Inspection Date: 2023-11-16
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1063911 - 2018-08-15](https://www.keypedia.com/records/fda_inspections/reprotech-llc/9b98c975-7621-44b0-b7b7-ded8b6e5ae59)
- [FDA Inspection 926110 - 2015-04-15](https://www.keypedia.com/records/fda_inspections/reprotech-llc/36a75913-3beb-4692-87d8-c831b2ad8aa6)
- [FDA Inspection 820977 - 2013-03-05](https://www.keypedia.com/records/fda_inspections/reprotech-llc/c4ebe409-69c7-4422-b331-d4ed795c0713)
- [FDA Inspection 701824 - 2010-12-14](https://www.keypedia.com/records/fda_inspections/reprotech-llc/24a5b3b3-854a-4a47-9837-9bd14d8fbf23)

Company: https://www.keypedia.com/companies/reprotech-llc/7f863ef8-9e6b-4711-8a79-e2450d0dd589

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d